H.C. Wainwright Maintains Orchestra BioMed(OBIO.US) With Buy Rating, Maintains Target Price $14

Moomoo NewsNov 14 09:33 ET · Ratings

We Think Orchestra BioMed Holdings (NASDAQ:OBIO) Needs To Drive Business Growth Carefully

Yahoo FinanceNov 14 05:05 ET

Chardan Capital Maintains Orchestra BioMed(OBIO.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsNov 13 00:33 ET · Ratings

Orchestra BioMed Holdings: Strategic Financial Developments and Clinical Progress Justify Buy Rating

TipRanksNov 13 00:15 ET · Ratings

Orchestra BioMed Reports Q EPS (41c), Consensus (43c)

TipRanksNov 12 17:40 ET

Orchestra BioMed Holdings 3Q Loss/Shr 41c >OBIO

Dow JonesNov 12 17:33 ET